[HTML][HTML] Endoplasmic reticulum stress: its role in disease and novel prospects for therapy

AH Schönthal - Scientifica, 2012 - hindawi.com
The endoplasmic reticulum (ER) is a multifunctional organelle required for lipid biosynthesis,
calcium storage, and protein folding and processing. A number of physiological and …

[HTML][HTML] Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment

K Gong, G Guo, N Beckley, Y Zhang, X Yang… - Neoplasia, 2021 - Elsevier
Tumor necrosis factor (TNF) and its receptors are widely expressed in non-small cell lung
cancer (NSCLC). TNF has an established role in inflammation and also plays a key role in …

Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancer

CWS Tong, WKK Wu, HHF Loong, WCS Cho, KKW To - Cancer letters, 2017 - Elsevier
The discovery of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) has
led to unprecedented clinical response in a subset of lung cancer patients carrying the …

[PDF][PDF] Crosstalk between G-protein-coupled receptors and epidermal growth factor receptor in cancer

NE Bhola, JR Grandis - Front Biosci, 2008 - article.imrpress.com
[Frontiers in Bioscience 13, 1857-1865, January 1, 2008] 1857 Crosstalk between G-protein-coupled
receptors and Epidermal growt Page 1 [Frontiers in Bioscience 13, 1857-1865, January 1 …

Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment

JM Lee, J Yanagawa, KA Peebles, S Sharma… - Critical reviews in …, 2008 - Elsevier
Lung carcinogenesis is a complex process involving the acquisition of genetic mutations that
confer cancer development and the malignant phenotype, and is critically linked to …

Targeting cancer-related inflammation with non-steroidal anti-inflammatory drugs: Perspectives in pharmacogenomics

H Lai, Y Liu, J Wu, J Cai, H Jie, Y Xu… - Frontiers in …, 2022 - frontiersin.org
Inflammatory processes are essential for innate immunity and contribute to carcinogenesis
in various malignancies, such as colorectal cancer, esophageal cancer and lung cancer …

Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs

AH Schönthal, TC Chen, FM Hofman… - Expert opinion on …, 2008 - Taylor & Francis
Celecoxib is an NSAID that was developed as a selective inhibitor of COX-2 and approved
by the FDA for the treatment of various forms of arthritis and the management of acute or …

COX‐2 inhibitors arrest prostate cancer cell cycle progression by down‐regulation of kinetochore/centromere proteins

J Bieniek, C Childress, MD Swatski, W Yang - The Prostate, 2014 - Wiley Online Library
BACKGROUND Previous studies have shown that COX‐2 inhibitors inhibit cancer cell
proliferation. However, the molecular mechanism remains elusive. METHODS Prostate …

The use of cyclooxygenase-2 inhibitors for improvement of efficacy of radiotherapy in cancers

E Salehifar, SJ Hosseinimehr - Drug Discovery Today, 2016 - Elsevier
Highlights•COX-2 is overexpressed in tumour cells and is involved in cell proliferation and
progression and angiogenesis.•COX-2 inhibitors can block various signalling pathways …

Targeted therapies for non–small cell lung cancer: an evolving landscape

SK Pal, RA Figlin, K Reckamp - Molecular cancer therapeutics, 2010 - AACR
Over the past decade, a multitude of targeted agents have been explored in the treatment of
advanced non–small cell lung cancer (NSCLC). Thus far, two broad classes of agents have …